Thursday, May 25, 2017

The Pharmacogenomics Journal - Table of Contents alert Volume 17 Issue 3

If you are unable to see the message below, click here to view.
The Pharmacogenomics Journal

Advertisement
IBS-NATURE CONFERENCE ON FRONTIERS IN GENOME ENGINEERING 

September 27-29, 2017 | Seoul, Korea

Presented by: Institute for Basic Science | Institute of Genetics and Developmental Biology, CAS | Nature | Nature Biotechnology

REGISTER NOW!

TABLE OF CONTENTS

Volume 17, Issue 3 (June 2017)

In this issue
Review
Original Articles

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
 

Review

Top

Pharmacogenetics of posttransplant diabetes mellitus

P Lancia, T Adam de Beaumais and E Jacqz-Aigrain

Pharmacogenomics J 2017 17: 209-221; advance online publication, March 28, 2017; 10.1038/tpj.2017.1

Abstract | Full Text

Original Articles

Top

Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner OPEN

E Theusch, K Kim, K Stevens, J D Smith, Y -D I Chen, J I Rotter, D A Nickerson and M W Medina

Pharmacogenomics J 2017 17: 222-229; advance online publication, March 1, 2016; 10.1038/tpj.2016.12

Abstract | Full Text

Blood gene expression profiling of an early acetaminophen response

P R Bushel, R D Fannin, K Gerrish, P B Watkins and R S Paules

Pharmacogenomics J 2017 17: 230-236; advance online publication, March 1, 2016; 10.1038/tpj.2016.8

Abstract | Full Text

FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitors

E Mendrinou, A Patsatsi, E Zafiriou, D Papadopoulou, L Aggelou, C Sarri, Z Mamuris, A Kyriakou, D Sotiriadis, A Roussaki-Schulze, T Sarafidou and Y Vasilopoulos

Pharmacogenomics J 2017 17: 237-241; advance online publication, April 5, 2016; 10.1038/tpj.2016.16

Abstract | Full Text

Genetic contribution of CYP1A1 variant on treatment outcome in epilepsy patients: a functional and interethnic perspective

P Talwar, N Kanojia, S Mahendru, R Baghel, S Grover, G Arora, G K Grewal, S Parween, A Srivastava, M Singh, S Vig, S Kushwaha, S Sharma, K Bala, Indian Genome Variation Consortium, S Kukreti and R Kukreti

Pharmacogenomics J 2017 17: 242-251; advance online publication, March 8, 2016; 10.1038/tpj.2016.1

Abstract | Full Text

Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer

M Gusella, S Giacopuzzi, L Bertolaso, A Zanoni, E Pezzolo, Y Modena, D Menon, P Paganin, J Weindelmayer, G Crepaldi, G De Manzoni and F Pasini

Pharmacogenomics J 2017 17: 252-257; advance online publication, March 1, 2016; 10.1038/tpj.2016.9

Abstract | Full Text

Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer

F Graziano, A Ruzzo, E Giacomini, T Ricciardi, G Aprile, F Loupakis, P Lorenzini, E Ongaro, F Zoratto, V Catalano, D Sarti, E Rulli, C Cremolini, M De Nictolis, G De Maglio, A Falcone, G Fiorentini and M Magnani

Pharmacogenomics J 2017 17: 258-264; advance online publication, March 1, 2016; 10.1038/tpj.2016.13

Abstract | Full Text

Association of thymidylate synthase polymorphisms with the tumor response to preoperative chemoradiotherapy in rectal cancer: a systematic review and meta-analysis

Y C Yang, G C Wu, L Jin, K L Wang, Z G Bai, J Wang and Z T Zhang

Pharmacogenomics J 2017 17: 265-273; advance online publication, March 22, 2016; 10.1038/tpj.2016.11

Abstract | Full Text

Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia

H Alachkar, N Fulton, B Sanford, G Malnassy, M Mutonga, R A Larson, C D Bloomfield, G Marcucci, Y Nakamura and W Stock

Pharmacogenomics J 2017 17: 274-279; advance online publication, March 29, 2016; 10.1038/tpj.2016.7

Abstract | Full Text

A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population

J Sun, M Zhu, W Shen, C Wang, J Dai, L Xu, G Jin, Z Hu, H Ma and H Shen

Pharmacogenomics J 2017 17: 280-285; advance online publication, March 8, 2016; 10.1038/tpj.2016.2

Abstract | Full Text

Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary

M B Hannouf, E Winquist, S M Mahmud, M Brackstone, S Sarma, G Rodrigues, P Rogan, J S Hoch and G S Zaric

Pharmacogenomics J 2017 17: 286-300; advance online publication, March 29, 2016; 10.1038/tpj.2015.94

Abstract | Full Text

 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature
 

No comments: